JHL will be participating in Bio Asia-Taiwan Exhibition 2020 on July 23-26. Welcome to meet us at Booth S709.
For online attendees, please go to https://bioasiataiwan.vfairs.com and search for JHL Biotech!
Visit the Event Website:
https://bioasiataiwan.com/en
Contact Us:
partnerwithjhl@edenbiologics.com
Tel: +886-3-658-3899
About JHL Biotech
JHL Biotech, Inc. is a biopharmaceutical startup founded by a group of industry veterans with deep experience in pharmaceutical development and operations. JHL is backed by premier financial firms, including Kleiner Perkins Caufield & Byers, Sequoia Capital, Biomark Capital, Milestone Capital, Fidelity, VMS Investment Group, and the China Development Industrial Bank. JHL Biotech’s mission is to provide the world with low-cost medicines of exceptional quality. JHL is focused on continuing to provide the highest-quality CDMO services for our esteemed clients and also research and development of new protein-based therapies and biosimilars. JHL has two world-class facilities built in accordance with United States, European Union, and ICH cGMP regulations and standards and can produce biological products to be marketed globally. For more information, please visit www.jhlbiotech.com.
Comments are closed.